Pepe (PEPE) price is approaching a key ascending trendline level at $0.0000103 at the time of writing on Tuesday. A daily close below this level would signal a correction ahead. On-chain data also supports the bearish outlook, as PEPE holders are realizing losses.Pepe (PEPE) price is approaching a key ascending trendline level at $0.0000103 at the time of writing on Tuesday. A daily close below this level would signal a correction ahead. On-chain data also supports the bearish outlook, as PEPE holders are realizing losses.

Pepe Price Prediction: PEPE risks breakdown as holders realize losses, momentum fades

3 min read
  • Pepe price is nearing an ascending trendline; a break below could trigger a sharp correction.
  • Santiment NPL data indicates that PEPE holders are realizing losses, signaling a waning confidence.
  • Momentum indicators are weakening, suggesting a potential double-digit crash ahead.

Pepe (PEPE) price is approaching a key ascending trendline level at $0.0000103 at the time of writing on Tuesday. A daily close below this level would signal a correction ahead. On-chain data also supports the bearish outlook, as PEPE holders are realizing losses. The frog-themed meme coin faces a heightened risk of a sharp pullback, as its momentum indicators show weakness, potentially leading to a double-digit decline on the horizon.

Pepe's on-chain metrics signal waning investors' confidence

Santiment’s Network Realized Profit/Loss (NPL) metric shows a bearish bias. The indicator decreased from 189,150 to -50.21 million between Sunday and Monday. This negative drop in the NPL metric indicates that PEPE's holders, on average, are realizing losses, signaling a waning of investors' confidence.

During the same day, Pepe's supply on exchanges metric rose from 103.55 trillion to 104.12 trillion. This increase in supply on exchanges indicates that holders are moving PEPE tokens to exchanges, which could increase selling activity, further supporting the bearish outlook.

Pepe’s NPL and Supply on Exchange chart. Source: Santiment

Pepe’s NPL and Supply on Exchange chart. Source: Santiment

IntoTheBlock on-chain signals summary, as shown in the chart below, also projects a bearish outlook.

Pepe Summary chart. Source: IntoTheBlock

Pepe Summary chart. Source: IntoTheBlock

Pepe Price Prediction: Momentum indicators show a bearish bias

Pepe price broke below its 50-day Exponential Moving Average (EMA) at $0.0000114 on Thursday and declined by nearly 9% until Monday. At the time of writing on Tuesday, PEPE is nearing an ascending trendline (drawn by connecting multiple lows since early April), coinciding with the daily support at $0.0000103, making it a key zone to watch.

If Pepe breaks below the ascending trendline and closes below $0.0000103 on a daily basis, it could extend the decline by 15% to retest its next daily support at $0.0000088. A successful close below this level could extend the decline toward $0.0000079, the next daily support level.

The Relative Strength Index (RSI) indicator on the daily chart reads 40 and points downward, indicating increasing bearish momentum. Moreover, the Moving Average Convergence Divergence (MACD) displayed a bearish crossover last week. It also shows red histogram bars below its neutral level, indicating a downward trend and further supporting the bearish thesis.

PEPE/USDT daily chart

PEPE/USDT daily chart

However, if Pepe finds support around the ascending trendline and recovers, it could extend the recovery toward the 50-day EMA at $0.0000114.


Market Opportunity
Pepe Logo
Pepe Price(PEPE)
$0.000004152
$0.000004152$0.000004152
-4.98%
USD
Pepe (PEPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29